GLPG - Galapagos NV Stock Trading

Galapagos NV(NASDAQ: GLPG) stock trading, description, contact, officers and directors.

About Galapagos NV

Galapagos is a midsized biotechnology company, with therapeutic programs based on proprietary disease modifying drug targets, and a focus on inflammation, orphan disease, and anti infectives. Galapagos approach is to develop drugs that stop or reverse a disease state using novel targets that are identified through a patent protected target discovery platform. Galapagos also provides access to its target and drug discovery platform through its services division, BioFocus and Argenta, which offers a full suite of target to drug discovery products and services to pharmaceutical and biotech companies.

Stock Information

Galapagos NV Company Name:

GLPG Stock Symbol:

NASDAQ Market:

Galapagos NV Website:

GLPG - Galapagos NV Stock Trading

GLPG GLPG Quote GLPG Short GLPG News GLPG Articles GLPG Message Board

Get GLPG Alerts

News, Short Squeeze, Breakout and More Instantly...

GLPG - GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Mechelen, Belgium ; 17 September 2021 ; 13.15 CET ; Galapagos NV (Euronext & Nasdaq: GLPG) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opi...
GLPG - Galapagos announces planned retirement of CEO

Mechelen, Belgium; 30 August 2021, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces the planned retirement of CEO Onno van de Stolpe. Onno van de Stolpe co-founded Galapagos in 1999 and built and led the company as CEO from its ear...
GLPG - Galapagos NV (GLPG) Q2 2021 Earnings Call Transcript

Image source: The Motley Fool. Galapagos NV (NASDAQ: GLPG) Q2 2021 Earnings Call Aug 6, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Galapagos NV (GLPG) Q2 2021 Earnings Call Transcript